Navigation Links
Lupus Research Institute Requests Strengthened NIH Funding for Biomedical Research in Debilitating Diseases like Lupus
Date:3/13/2013

WASHINGTON, March 13, 2013 /PRNewswire/ -- The Lupus Research Institute (LRI) calls for Congressional budget action to sustain the nation's biomedical research enterprise at the National Institutes of Health (NIH). Speaking on behalf of the lupus community throughout the country, the LRI testified before the Fiscal 2014 Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies Public Witness Hearing. The Hearing is being held as the first phase of sequestration to federally funded programs is underway, with anticipated cuts of $1.6 billion to NIH budgets. 

Renowned rheumatologist and lupus expert Dr. Richard Furie of New York's North Shore-LIJ Health System represented the LRI, providing both written and oral testimony. He pointed to the critical need to provide safe and effective treatments to the millions suffering with the devastating autoimmune disease lupus and emphasized the implications of research into lupus as the prototype for the 100+ autoimmune diseases affecting one out of every five Americans.

Lupus a Devastating Disease Affecting 1.5 Million Americans 
To foster an appreciation for the magnitude of suffering that lupus brings, Dr. Furie asked the Subcommittee to imagine a disease with no known cause or cure that is a leading cause of heart attack, stroke and kidney disease among young women. He went on to describe lupus as a disease that strikes without warning, strikes at random, attacking the brain, heart, lungs, or blood -- virtually any human organ and tissue.

"During the course of my career, approximately 100 of my lupus patients have died, and countless have had strokes or have gone on to kidney failure and required dialysis," Dr. Furie commented.  "I could fill the entire day with heartbreaking stories. Our goal is to cure this disease so there are no more stories."

Importance of NIH Research Funding 
Dr. Furie highlighted the value of a strong, vibrant biomedical research enterprise fueled and led by the NIH.  "Clearly, tomorrow's advances in lupus and other autoimmune diseases depend on today's investments in NIH research. Sustained, dependable, long-term growth in NIH-funded medical research brings the promise of new knowledge and technologies in pursuit of cures for patients. The NIH mission is critical, as is its support in maintaining our global leadership in biomedical research and development. The fiscal climate of the past few years has threatened the stability of the biomedical research enterprise."

The LRI petitions for $30 billion in Fiscal 2014 appropriations, representing a modest increase of 2.7 percent to allow the NIH to continue to innovate in areas of exceptional promise with the potential to save lives and reduce the burden of disease. 

"We respectfully urge Congress and the Administration to work together on a solution that addresses the nation's fiscal needs while preserving the national investment in biomedical research and the health of the American people," concluded Dr. Furie.

President and CEO of the Lupus Research Institute Margaret Dowd commented, "Affecting 1.5 million Americans, lupus poses a serious public health and women's health issue. People with lupus waited 50 years for just one new treatment and support for research is essential to ensure they don't have to wait another half century for the next sorely needed breakthrough."

About The Lupus Research Institute 
The Lupus Research Institute (LRI), the world's leading private supporter of innovative research, pioneers discovery and champions scientific creativity to find solutions to lupus.

 


'/>"/>
SOURCE The Lupus Research Institute
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. A nanogel-based treatment for lupus
2. Karyopharm Therapeutics Announces Oral Presentation at the American College of Rheumatology (ACR) on the use of Selective Inhibitors of Nuclear Export (SINE) CRM1 Antagonists in preclinical models of Systemic Lupus Erythematosus (SLE)
3. Lupus Research Institute Awards $3.6 Million for Novel Studies Driving Wide-Ranging New Science in Lupus
4. Exagen Diagnostics Launches Cutting-Edge Lupus Diagnostic
5. Peptide Therapeutics Market is Expected to Reach USD 25.4 Billion Globally in 2018: Transparency Market Research
6. Research and Markets Announces the Release of Transdermal Pain Management to 2016. Products, Markets, Forecasts and Opportunities
7. PwCs Health Research Institute Finds Shortage of Health IT Workers Could Slow Industry Progress
8. Stem Cell / Regenerative Medicine & HSCT / Cord Blood Market Analysis in New Research Report at ReportsnReports.com
9. The Hartwell Foundation Provides Grant to University of Michigan Researchers
10. New Strain of Bacteria May Clear up Acne Probiotic Action Explains the New Research Findings from Washington University
11. Global Implantable Drug Delivery Devices Market - New Industry Research Report Published by Transparency Market Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample tracking software ... State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. , ... Tremblay, President and COO of STACS DNA. “In further expanding our capacity as a ...
(Date:6/23/2016)... June 23, 2016  Blueprint Bio, a company dedicated ... the medical community, has closed its Series A funding ... . "We have received a commitment from ... we need to meet our current goals," stated ... the runway to complete validation on the current projects ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... the Pennsylvania Convention Center and will showcase its product’s latest features from June ... be presenting a scientific poster on Disrupting Clinical Trials in The Cloud during ...
(Date:6/23/2016)... FRANCISCO , June 22, 2016  Amgen (NASDAQ: ... sponsorship of the QB3@953 life sciences incubator ... human health. The shared laboratory space at QB3@953 was ... overcome a key obstacle for many early stage organizations ... part of the sponsorship, Amgen launched two "Amgen Golden ...
Breaking Biology Technology:
(Date:6/16/2016)... , June 16, 2016 ... size is expected to reach USD 1.83 billion ... Grand View Research, Inc. Technological proliferation and increasing ... applications are expected to drive the market growth. ... , The development of advanced multimodal ...
(Date:6/9/2016)... -- Paris Police Prefecture ... to ensure the safety of people and operations in several ... tournament Teleste, an international technology group specialised in ... that its video security solution will be utilised by ... safety across the country. The system roll-out is scheduled for ...
(Date:6/2/2016)... The Department of Transport Management (DOTM) of ... Dollar project, for the , Supply and Delivery ... IT Infrastructure , to Decatur ... Identity Management Solutions. Numerous renowned international vendors participated in the ... was selected for the most compliant and innovative solution. The ...
Breaking Biology News(10 mins):